Literature DB >> 25894667

Therapeutic alliance in a randomized clinical trial for bulimia nervosa.

Erin C Accurso1, Ellen E Fitzsimmons-Craft1, Anna Ciao1, Li Cao2, Ross D Crosby2, Tracey L Smith3, Marjorie H Klein4, James E Mitchell2, Scott J Crow5, Stephen A Wonderlich2, Carol B Peterson5.   

Abstract

OBJECTIVE: This study examined the temporal relation between therapeutic alliance and outcome in two treatments for bulimia nervosa (BN).
METHOD: Eighty adults with BN symptoms were randomized to 21 sessions of integrative cognitive-affective therapy (ICAT) or enhanced cognitive-behavioral therapy (CBT-E). Bulimic symptoms (i.e., frequency of binge eating and purging) were assessed at each session and posttreatment. Therapeutic alliance (Working Alliance Inventory) was assessed at Sessions 2, 8, 14, and posttreatment. Repeated-measures analyses using linear mixed models with random intercepts were conducted to determine differences in alliance growth by treatment and patient characteristics. Mixed-effects models examined the relation between alliance and symptom improvement.
RESULTS: Overall, patients in both treatments reported strong therapeutic alliances. Regardless of treatment, greater therapeutic alliance between (but not within) subjects predicted greater reductions in bulimic behavior; reductions in bulimic behavior also predicted improved alliance. Patients with higher depression, anxiety, or emotion dysregulation had a stronger therapeutic alliance in CBT-E than ICAT, while those with more intimacy problems had greater improvement in therapeutic alliance in ICAT compared to CBT-E.
CONCLUSIONS: Therapeutic alliance has a unique impact on outcome, independent of the impact of symptom improvement on alliance. Within- and between-subjects effects revealed that changes in alliance over time did not predict symptom improvement, but rather that individuals who had a stronger alliance overall had better bulimic symptom outcomes. These findings indicate that therapeutic alliance is an important predictor of outcome in the treatment of BN. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 25894667      PMCID: PMC4446165          DOI: 10.1037/ccp0000021

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  16 in total

1.  Engagement and outcome in the treatment of bulimia nervosa: first phase of a sequential design comparing motivation enhancement therapy and cognitive behavioural therapy.

Authors:  J L Treasure; M Katzman; U Schmidt; N Troop; G Todd; P de Silva
Journal:  Behav Res Ther       Date:  1999-05

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  The working alliance: Where are we and where should we go?

Authors:  Louis G Castonguay; Michael J Constantino; Martin Grosse Holtforth
Journal:  Psychotherapy (Chic)       Date:  2006

4.  Working alliance predicts psychotherapy outcome even while controlling for prior symptom improvement.

Authors:  Fredrik Falkenström; Fredrik Granström; Rolf Holmqvist
Journal:  Psychother Res       Date:  2013-11-05

5.  Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change.

Authors:  G T Wilson; K L Loeb; B T Walsh; E Labouvie; E Petkova; X Liu; C Waternaux
Journal:  J Consult Clin Psychol       Date:  1999-08

6.  Between-therapist and within-therapist differences in the quality of the therapeutic relationship: effects on maladjustment and self-critical perfectionism.

Authors:  David C Zuroff; Allison C Kelly; Michelle J Leybman; Sidney J Blatt; Bruce E Wampold
Journal:  J Clin Psychol       Date:  2010-07

7.  A randomized controlled comparison of integrative cognitive-affective therapy (ICAT) and enhanced cognitive-behavioral therapy (CBT-E) for bulimia nervosa.

Authors:  S A Wonderlich; C B Peterson; R D Crosby; T L Smith; M H Klein; J E Mitchell; S J Crow
Journal:  Psychol Med       Date:  2013-05-23       Impact factor: 7.723

Review 8.  The disaggregation of within-person and between-person effects in longitudinal models of change.

Authors:  Patrick J Curran; Daniel J Bauer
Journal:  Annu Rev Psychol       Date:  2011       Impact factor: 24.137

9.  Does alliance predict symptoms throughout treatment, or is it the other way around?

Authors:  Sigal Zilcha-Mano; Ulrike Dinger; Kevin S McCarthy; Jacques P Barber
Journal:  J Consult Clin Psychol       Date:  2013-11-25

Review 10.  The role of interpersonal functioning in the maintenance of eating psychopathology: a systematic review and testable model.

Authors:  Jon Arcelus; Michelle Haslam; Claire Farrow; Caroline Meyer
Journal:  Clin Psychol Rev       Date:  2012-11-10
View more
  4 in total

1.  The effects of psychotherapy treatment on outcome in bulimia nervosa: Examining indirect effects through emotion regulation, self-directed behavior, and self-discrepancy within the mediation model.

Authors:  Carol B Peterson; Kelly C Berg; Ross D Crosby; Jason M Lavender; Erin C Accurso; Anna C Ciao; Tracey L Smith; Marjorie Klein; James E Mitchell; Scott J Crow; Stephen A Wonderlich
Journal:  Int J Eat Disord       Date:  2017-01-24       Impact factor: 4.861

2.  Examining the Acceptability of a Resilience Building Intervention Among Adults Aging With HIV.

Authors:  Pariya L Fazeli; Cierra N Hopkins; Andrea Wells; Crystal Chapman Lambert; Bulent Turan; Mirjam-Colette Kempf; David E Vance
Journal:  J Assoc Nurses AIDS Care       Date:  2022 Mar-Apr 01       Impact factor: 1.354

3.  Proof of Concept of the Contribution of the Interaction between Trait-like and State-like Effects in Identifying Individual-Specific Mechanisms of Action in Biological Psychiatry.

Authors:  Sigal Zilcha-Mano; Nili Solomonov; Jonathan E Posner; Steven P Roose; Bret R Rutherford
Journal:  J Pers Med       Date:  2022-07-23

Review 4.  Alliance matters: but how much? A systematic review on therapeutic alliance and outcome in patients with anorexia nervosa and bulimia nervosa.

Authors:  Janina Werz; Ulrich Voderholzer; Brunna Tuschen-Caffier
Journal:  Eat Weight Disord       Date:  2021-08-10       Impact factor: 3.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.